Cargando…

Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey

INTRODUCTION: Paediatric plaque psoriasis (PedPso) in children and adolescents is often diagnosed and treated for the first time by paediatricians. An early onset of psoriasis is associated with a genetic family burden, higher severity of disease and increased risk of comorbidities, sometimes starti...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinter, Andreas, Mielke, Nicole, Malisiewicz, Bartosz, Kaufmann, Roland, König, Anke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367944/
https://www.ncbi.nlm.nih.gov/pubmed/32419097
http://dx.doi.org/10.1007/s13555-020-00390-y
_version_ 1783560517897420800
author Pinter, Andreas
Mielke, Nicole
Malisiewicz, Bartosz
Kaufmann, Roland
König, Anke
author_facet Pinter, Andreas
Mielke, Nicole
Malisiewicz, Bartosz
Kaufmann, Roland
König, Anke
author_sort Pinter, Andreas
collection PubMed
description INTRODUCTION: Paediatric plaque psoriasis (PedPso) in children and adolescents is often diagnosed and treated for the first time by paediatricians. An early onset of psoriasis is associated with a genetic family burden, higher severity of disease and increased risk of comorbidities, sometimes starting in childhood. However, little information is available on prevalence data and the clinical management of PedPso by paediatricians. METHODS: A total of 191 questionnaires were sent out to paediatricians regarding their management of PedPso, with a focus on prevalence, diagnosis, initiation of therapies, screening for comorbidities and collaboration with dermatologists. Of these, 95 (49.7%) were returned and evaluated anonymously. RESULTS: Only about one-half of the responding paediatricians reported being certain in their diagnosis of PedPso, even though they regularly see moderate-to-severely affected patients. The questionnaire revealed that there are clear differences in the general management of PedPso if the paediatrician is not certain of the diagnosis of psoriasis. Compared to paediatricians certain of their diagnosis, those who are uncertain less frequently perform whole-body inspection, screen for relevant comorbidities, such as psoriasis arthritis, metabolic syndrome or mental disorders, and prescribe the use of topical or systemic therapies. No responding paediatrician reported the use of modern systemic therapies, such as biologicals, even in severely affected children. The majority of respondents rated their cooperation with dermatologists as good. CONCLUSION: The certainty of the diagnosis, the use of system therapies and the screening for comorbidity could improve the care of PedPso through targeted training of paediatricians and intensified interdisciplinary cooperation with dermatologist. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13555-020-00390-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7367944
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-73679442020-07-22 Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey Pinter, Andreas Mielke, Nicole Malisiewicz, Bartosz Kaufmann, Roland König, Anke Dermatol Ther (Heidelb) Original Research INTRODUCTION: Paediatric plaque psoriasis (PedPso) in children and adolescents is often diagnosed and treated for the first time by paediatricians. An early onset of psoriasis is associated with a genetic family burden, higher severity of disease and increased risk of comorbidities, sometimes starting in childhood. However, little information is available on prevalence data and the clinical management of PedPso by paediatricians. METHODS: A total of 191 questionnaires were sent out to paediatricians regarding their management of PedPso, with a focus on prevalence, diagnosis, initiation of therapies, screening for comorbidities and collaboration with dermatologists. Of these, 95 (49.7%) were returned and evaluated anonymously. RESULTS: Only about one-half of the responding paediatricians reported being certain in their diagnosis of PedPso, even though they regularly see moderate-to-severely affected patients. The questionnaire revealed that there are clear differences in the general management of PedPso if the paediatrician is not certain of the diagnosis of psoriasis. Compared to paediatricians certain of their diagnosis, those who are uncertain less frequently perform whole-body inspection, screen for relevant comorbidities, such as psoriasis arthritis, metabolic syndrome or mental disorders, and prescribe the use of topical or systemic therapies. No responding paediatrician reported the use of modern systemic therapies, such as biologicals, even in severely affected children. The majority of respondents rated their cooperation with dermatologists as good. CONCLUSION: The certainty of the diagnosis, the use of system therapies and the screening for comorbidity could improve the care of PedPso through targeted training of paediatricians and intensified interdisciplinary cooperation with dermatologist. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13555-020-00390-y) contains supplementary material, which is available to authorized users. Springer Healthcare 2020-05-18 /pmc/articles/PMC7367944/ /pubmed/32419097 http://dx.doi.org/10.1007/s13555-020-00390-y Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Pinter, Andreas
Mielke, Nicole
Malisiewicz, Bartosz
Kaufmann, Roland
König, Anke
Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey
title Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey
title_full Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey
title_fullStr Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey
title_full_unstemmed Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey
title_short Management of Paediatric Psoriasis by Paediatricians: A Questionnaire-Based Survey
title_sort management of paediatric psoriasis by paediatricians: a questionnaire-based survey
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367944/
https://www.ncbi.nlm.nih.gov/pubmed/32419097
http://dx.doi.org/10.1007/s13555-020-00390-y
work_keys_str_mv AT pinterandreas managementofpaediatricpsoriasisbypaediatriciansaquestionnairebasedsurvey
AT mielkenicole managementofpaediatricpsoriasisbypaediatriciansaquestionnairebasedsurvey
AT malisiewiczbartosz managementofpaediatricpsoriasisbypaediatriciansaquestionnairebasedsurvey
AT kaufmannroland managementofpaediatricpsoriasisbypaediatriciansaquestionnairebasedsurvey
AT koniganke managementofpaediatricpsoriasisbypaediatriciansaquestionnairebasedsurvey